LUDIOMIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ludiomil, and when can generic versions of Ludiomil launch?
Ludiomil is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in LUDIOMIL is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
Summary for LUDIOMIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Patent Applications: | 884 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LUDIOMIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LUDIOMIL
US Patents and Regulatory Information for LUDIOMIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | LUDIOMIL | maprotiline hydrochloride | TABLET;ORAL | 017543-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | LUDIOMIL | maprotiline hydrochloride | TABLET;ORAL | 017543-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | LUDIOMIL | maprotiline hydrochloride | TABLET;ORAL | 017543-003 | Sep 30, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |